For the latest COVID-19 campus news and resources, visit umassmed.edu/coronavirus.

Search Close Search
Search Close Search
Page Menu

UMass Chan Medical School strives to catalyze our world-class basic research into scientific discoveries with high impact clinical applications and overcome the barriers in translating knowledge into clinical practice.

Established in 1970, UMass Chan has rapidly grown into a highly productive, highly collaborative research enterprise with outstanding scientific resources and facilities. UMass Chan receives more than $300 million per year in research funding. Our research community includes a Nobel laureate, a Lasker award recipient, seven National Academy members and four Howard Hughes Medical Institute investigators. Our research achievements have impacted the lives of children and adults in the U.S. and across the globe.

Research news

Getting Results…
  • NeuShen Therapeutics funds ALS research at UMass Chan Medical School
    Research News

    NeuShen Therapeutics funds ALS research at UMass Chan Medical School

    UMass Chan Medical School has signed a three-year sponsored research agreement with NeuShen Therapeutics Inc. to investigate a gene therapy treatment for amyotrophic lateral sclerosis. Jun Xie, PhD, and Guangping Gao, PhD, are leading the project for UMass Chan.

    Read more
  • UMass Chan Medical School licenses data processing and analysis technology to Via Scientific
    Research News

    UMass Chan Medical School licenses data processing and analysis technology to Via Scientific

    UMass Chan Medical School has licensed the rights to develop and commercialize a bioinformatic software platform developed by UMass Chan researchers Alper Kucukural, PhD, and Manuel Garber, PhD, and colleagues in the UMass Chan Bioinformatics Core to Via Scientific Inc., in Cambridge

    Read more
  • Head shot of David Keener, Phd candidate in the Morningside Graduate School of Biomedical Sciences
    Research News

    PhD candidate awarded NIH Kirschstein Award for research on Rett syndrome

    PhD candidate David Keener has received a National Institutes of Health grant to fund his research project on Rett syndrome, a genetic neurodevelopmental disease generally diagnosed in girls ages 6 to 18 months.

    Read more
  • LISTEN: Physician-scientist Jeremy Luban reflects on lessons learned from the COVID-19 pandemic
    Research News

    LISTEN: Physician-scientist Jeremy Luban reflects on lessons learned from the COVID-19 pandemic

    Jeremy Luban, MD, discusses the latest SARS COV-2 variant of concern and the future of vaccines in the fight against COVID in a new Voices of UMass Chan podcast.

    Read more
  • Vivian Budnik named fellow of the American Association for the Advancement of Science
    Research News

    Vivian Budnik named fellow of the American Association for the Advancement of Science

    Vivian Budnik, PhD, has been elected as a fellow of the American Association for the Advancement of Science for her contributions to the understanding of the mechanisms of synaptic signaling.

    Read more
  • Ana Rita Batista, PhD, (left) instructor in neurology, pictured with Miguel Sena-Esteves, PhD, associate professor of neurology and director of the Translational Institute for Molecular Therapeutics..
    Media, Research News

    UMass Chan researchers achieve gene therapy milestone for potential Cockayne syndrome treatment

    Researchers working with UMass Chan Medical School’s Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare and fatal neurodegenerative disease that largely affects children and young adults.

    Read more